CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 29.84
-2.20 (-6.87%)
Apr 29, 2026, 4:08 PM HKT
CanSino Biologics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 27.87 | -378.88 | -1,483 | -909.43 | 1,914 | Upgrade
|
| Depreciation & Amortization | 169.92 | 205.83 | 263.24 | 189.22 | 73.36 | Upgrade
|
| Other Amortization | 6.77 | 11 | 6.3 | 7.14 | 15.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.14 | 0.02 | -0.02 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.41 | 1.32 | 362.7 | 0.25 | 0.25 | Upgrade
|
| Loss (Gain) From Sale of Investments | -32.15 | 43.1 | -42.63 | -76.63 | -71.86 | Upgrade
|
| Stock-Based Compensation | 9.38 | 3.2 | 9.54 | 10.08 | 9.8 | Upgrade
|
| Provision & Write-off of Bad Debts | 12.52 | 11.17 | 15.05 | 8.78 | 1.82 | Upgrade
|
| Other Operating Activities | 63.02 | 64.24 | 139.98 | 624.87 | -6.58 | Upgrade
|
| Change in Accounts Receivable | -52.97 | -78.56 | 265.97 | -495.8 | -419.94 | Upgrade
|
| Change in Inventory | -87.95 | -0.68 | -216.54 | -604.02 | -706.39 | Upgrade
|
| Change in Accounts Payable | 16.38 | -106.27 | -223.19 | -429.93 | 1,212 | Upgrade
|
| Change in Unearned Revenue | -35.92 | 54.38 | -5.64 | 20.88 | 27.52 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.38 | 11.2 | - | - | Upgrade
|
| Operating Cash Flow | 90.98 | -167.29 | -908.23 | -1,852 | 2,050 | Upgrade
|
| Capital Expenditures | -243.9 | -457.64 | -610.47 | -1,075 | -1,203 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.56 | 0.04 | 0.31 | - | - | Upgrade
|
| Cash Acquisitions | - | -1.31 | -0.34 | - | - | Upgrade
|
| Investment in Securities | 550.73 | 377.48 | 99.25 | -697.83 | -1,403 | Upgrade
|
| Other Investing Activities | 44.97 | 83.89 | 61.59 | 545.21 | 45.77 | Upgrade
|
| Investing Cash Flow | 352.36 | 2.46 | -449.65 | -1,228 | -2,560 | Upgrade
|
| Short-Term Debt Issued | - | - | 50.46 | - | - | Upgrade
|
| Long-Term Debt Issued | 795.66 | 1,043 | 1,635 | 2,634 | 1,150 | Upgrade
|
| Total Debt Issued | 795.66 | 1,043 | 1,685 | 2,634 | 1,150 | Upgrade
|
| Short-Term Debt Repaid | - | - | -20.58 | - | - | Upgrade
|
| Long-Term Debt Repaid | -1,517 | -1,314 | -1,615 | -1,388 | -181 | Upgrade
|
| Total Debt Repaid | -1,517 | -1,314 | -1,636 | -1,388 | -181 | Upgrade
|
| Net Debt Issued (Repaid) | -721.74 | -270.47 | 49.32 | 1,246 | 969.13 | Upgrade
|
| Issuance of Common Stock | - | - | 16.98 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -150.17 | - | Upgrade
|
| Common Dividends Paid | -44.51 | -63.78 | -73.75 | -241.28 | -14.1 | Upgrade
|
| Other Financing Activities | -0.65 | 0.07 | -0.14 | -0.37 | 598.59 | Upgrade
|
| Financing Cash Flow | -766.9 | -334.18 | -7.58 | 854.23 | 1,554 | Upgrade
|
| Foreign Exchange Rate Adjustments | -12.98 | 8.72 | 20.29 | 160.76 | -33.78 | Upgrade
|
| Net Cash Flow | -336.54 | -490.29 | -1,345 | -2,064 | 1,009 | Upgrade
|
| Free Cash Flow | -152.92 | -624.93 | -1,519 | -2,927 | 846.86 | Upgrade
|
| Free Cash Flow Margin | -14.32% | -73.84% | -425.31% | -282.87% | 19.70% | Upgrade
|
| Free Cash Flow Per Share | -0.60 | -2.52 | -6.16 | -11.84 | 3.42 | Upgrade
|
| Cash Income Tax Paid | 40.89 | 25.19 | -24.05 | -77.91 | -162.45 | Upgrade
|
| Levered Free Cash Flow | -317.94 | -843.19 | -908.45 | -2,557 | 185.99 | Upgrade
|
| Unlevered Free Cash Flow | -293.18 | -805.7 | -868.36 | -2,531 | 198.76 | Upgrade
|
| Change in Working Capital | -166.62 | -128.3 | -179.65 | -1,706 | 113.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.